GLP-1
Clinical Guide

Publication information

The source record

Choose a document by the question it helps you examine; retain its date and limits.

Clarify the term and the product

Begin with approved, off-label and compounded terminology. Its source notes distinguish the documents used for each explanation. Keep the exact product, intended use and document edition with the question; this index does not assemble instructions for an individual prescription.

Relevant records: the original off-label explainer, labeling guidance and the Foundayo label used in the oral-trial analysis. Earlier check dates remain visible. A newly retrieved label does not refresh a different blocked or historical source.

Prepare a clinical conversation

The follow-up preparation guide provides a record for observations and questions. Pair it with the test-purpose guide and the plan-clarification guide. Use them to identify what you need the responsible professional to explain, not to infer a personal schedule.

Compare the original NIDDK record with the separate November 13 retrieval. The document's June 2024 review date remains distinct. The older FDA and NIA records were not all freshly retrieved; the later check does not validate every earlier attribution.

Read the service and payment record

The twelve-provider comparison organizes product, responsibility and payment questions. A provider page records what the company advertised; it does not establish a selected agreement, actual care, pharmacy inspection or customer-service performance. Open the linked profile to see the dated observation and unresolved terms.

November 13 supplements cover CoreAge's offer and terms, SuperHealthy, Likeness and WeightWatchers. Other provider records remain historical. An offer date and a page-modification date answer different questions.

Read the study in its own context

Use the ATTAIN-1 analysis or ESSENCE analysis to follow the source-to-result discussion, including the existing tables and downloadable graph data. Keep each population, analysis and source edition attached to its result. These articles do not compare the clinical quality of the services in our promotional shortlist.

The historical research abstracts and chart values retain their original source records. The November 13 label retrieval does not replace the historical ATTAIN-1 abstract or its plotted analysis. Read the limitations in the scientific article before carrying a result into another context.

Source notes

Supplemental checks are dated November 13, 2026. Earlier records retain their original check dates; a new page edit does not refresh every source. Provider pages document advertised terms. Study summaries identify the scope of our review.

  1. FDA — unapproved uses of approved drugsRegulatory terminology · Original check October 5, 2026
  2. FDA — finding out whether a drug is approvedOfficial approval lookup guidance · Original check October 5, 2026
  3. FDA — compounding questions and answersCompounded-product context · Original check October 5, 2026
  4. FDA — concerns with unapproved GLP-1 productsMedication safety context · Checked 2026-10-21
  5. NIA — questions to ask during a checkupPatient communication guidance · Original check October 5, 2026
  6. NIA — talking with your doctor worksheetsPatient preparation resources · Original check October 5, 2026
  7. FDA — create and keep a medication listMedication-record guidance · Original check October 5, 2026
  8. FDA — prescription labeling questions and answersLabeling guidance · Original check October 5, 2026
  9. CoreAge Rx — semaglutide product offerProvider advertisement · Original check October 5, 2026
  10. CoreAge Rx — tirzepatide product offerProvider advertisement · Original check October 5, 2026
  11. CoreAge Rx — pricing and plan termsProvider policy · Original check October 5, 2026
  12. SuperHealthy Rx — GLP-1 offerProvider promotion · Original check October 5, 2026
  13. Likeness Rx — GLP-1 offer and termsProvider policy · Original check October 5, 2026
  14. Ro — Body programProvider membership offer · Original check October 5, 2026
  15. WeightWatchers — Med+ medication programProvider membership offer · Original check October 5, 2026
  16. LillyDirect — access to medicines and independent careManufacturer access pathway · Original check October 5, 2026
  17. Prescription Medications to Treat Overweight & Obesity - NIDDKPrimary health resource; checked October 5, 2026
  18. Understanding Unapproved Use of Approved Drugs "Off Label"Federal patient information; checked October 5, 2026
  19. Frequently Asked Questions (FAQs) | Form HealthProvider public offer; checked October 5, 2026
  20. Frequently Asked Questions | LifeMD®Provider public offer; checked October 5, 2026
  21. It can be a lifesaving tool, especially during an emergencyPrimary health resource; checked October 5, 2026
  22. What Should I Ask My Doctor During a Checkup?Primary health resource; checked October 5, 2026
  23. BeSafeRx: Frequently Asked Questions (FAQs)Primary health resource; checked October 5, 2026
  24. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight LossPrimary health resource; checked October 5, 2026
  25. Safely Using Sharps (Needles and Syringes)Federal patient information; checked October 5, 2026
  26. What is the cost of medication? - Form Health Patient Support CenterProvider public offer; checked October 5, 2026
  27. Medical Weight Loss Programs Available OnlineProvider public offer; checked October 5, 2026
  28. How It Works - PlushCareProvider public offer; checked October 5, 2026
  29. Weight Management Program Overview | LifeMD®Provider public offer; checked October 5, 2026
  30. Programs & Membership Plans | LifeMD®️Provider public offer; checked October 5, 2026
  31. Henry | Personalized Weight Loss, Hormone & Sexual Health CareProvider public offer; checked October 5, 2026
  32. Henry | Personalized Weight Loss, Hormone & Sexual Health CareProvider public offer; checked October 5, 2026
  33. AFC: National weight-management program and location limitsProvider public information; checked October 15, 2026
  34. AFC Denver Leetsdale: Local medication prices and prepaid membership termsProvider public information; checked October 15, 2026
  35. Blue Sky MD: GLP-1 prices, required program and outcome claimsProvider public information; checked October 15, 2026
  36. Blue Sky MD: Medical weight-loss program and insuranceProvider public information; checked October 15, 2026
  37. Blue Sky MD: Online visits and in-person requirementsProvider public information; checked October 15, 2026
  38. Blue Sky MD: Website operator and privacy policyProvider public information; checked October 15, 2026
  39. FDA: Concerns with unapproved GLP-1 drugs used for weight lossMedication safety context; checked October 15, 2026
  40. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.Indexed original research abstract · Checked 2026-10-21
  41. FDA approves treatment for serious liver disease known as MASHOfficial FDA page read through web tool; historical approval announcement, not complete current labeling · Checked 2026-10-21
  42. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.Primary research or official information · Checked 2026-10-21
  43. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.Primary research or official information · Checked 2026-10-21
  44. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment.Indexed original research abstract · Checked 2026-10-21
  45. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity.Indexed original research abstract · Checked 2026-10-21
  46. DailyMed - FOUNDAYO- orforglipron tablet, film coatedOfficial page retrieved in full · Checked 2026-10-21
  47. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.Primary research or official information · Checked 2026-10-21
  48. CoreAge Rx — semaglutide offer, November 13 snapshotProvider advertisement; conflicting price surfaces · Checked November 13, 2026
  49. CoreAge Rx — pricing and plans, October 30 editionProvider policy; selected order not tested · Checked November 13, 2026
  50. SuperHealthy Rx — November 13 offer and termsProvider promotion; checkout agreement not retrieved · Checked November 13, 2026
  51. Likeness Rx — November 13 GLP-1 offer and termsProvider advertisement; selected agreement not tested · Checked November 13, 2026
  52. WeightWatchers Med+ — selected offer ending November 14, 2026Dated membership offer; not a future availability guarantee · Checked November 13, 2026
  53. NIDDK — prescription weight-management medicines, June 2024 reviewGeneral patient education; review date June 2024 · Checked November 13, 2026
  54. DailyMed — Foundayo label, July 29, 2026 editionOfficial label; supplemental retrieval · Checked November 13, 2026